HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries

5 Questions with a Health Policy Specialist: Deborah Godes

Deborah Godes
Focus Area: Market Access Strategies
Office: Washington, D.C.
Years at McDermott+Consulting: 8


What is your favorite part about your health policy work at McDermott+Consulting?
For me, I love the people with whom I work. It may sound a bit cliché but the people on the Market Access team at McDermottPlus each contribute in a critical way, whether it is their wealth of knowledge from their decades of experience, their analytical approach to challenges and their expertise with critical data sets, or their fresh perspective to an ongoing challenge. While we may have different roles and responsibilities in the development or execution of the strategy, we are always working together as one with the client to achieve the optimal outcome.

What is the biggest opportunity and greatest challenge facing clients in your area of focus today?
I work with clients that are bringing innovative solutions to the market whether diagnostic tests, medical devices or healthcare services, a number of which are artificial intelligence-based solutions. The biggest opportunity and the greatest challenge for our clients is the level of uncertainty from a reimbursement perspective. Some clients are introducing new concepts that the Administration has not considered previously which creates opportunities for these companies to set new precedent. However, the novelty creates challenges because the Administration may not have historically viewed medical devices or diagnostic tests in that way so it requires a change in [...]

Continue Reading




5 Questions with a Life Sciences Lawyer: Doug Carsten

Doug H. Carsten
Practice Focus Area: Patient Litigation
Office: Orange County
Years at Firm: Joined in March 2021

What is your favorite part about practicing life sciences law at McDermott?
I love working with the incredibly talented partners and associates in MWE’s life sciences group. The level of disparate practice group talent here is remarkable, and I am so excited to collaborate with this team to help our fantastic life sciences clients.

What is the biggest opportunity and greatest challenge facing clients in your area of focus today?
Biggest opportunity: To work with our life sciences team!
Seriously, the biggest opportunity and challenge facing our life sciences clients are the same – the current pandemic landscape. As an opportunity, life sciences companies have never before been so much in the spotlight and viewed as a potential answer to the COVID-19 virus. On the other hand, the very nature of the pandemic has deeply affected and really changed how life sciences – and all companies – conduct business.

What kind of client work gets you most excited when it comes across your desk?
My true love is trying cases. It doesn’t matter what the issue is – if there is a trial involved, I am excited. Secondarily, I really enjoy unpacking complex fact patterns and developing strategies that the client hadn’t thought of to get around particular challenges.

What is the proudest [...]

Continue Reading




HPE New York 2021: The Need for Speed

 

In today’s supercharged private equity market, being a buyer is a tricky position. It’s tough to win deals and even more challenging to get them signed and closed on sellers’ extremely tight deadlines. Krist Werling, partner and co-head of the Private Equity Practice Group at McDermott, was joined by industry leaders to discuss these issues and the dynamics facing those on the buy side of healthcare private equity. The panel included:

  • Paige Daly, Partner, Harvest Partners
  • Sean Dempsey, Partner, Sheridan Capital Partners
  • Carmine Petrone, Managing Director, Advent International
  • Neel Varshney, MD, Founding Partner, Patient Square Capital

Access the full takeaways here.
Watch the session recording here.




HPE New York 2021: Big Bankers Breakfast

 

The second year of the Biden administration and the potential ending of a world-shifting pandemic will surely shape the 2022 healthcare investing market. To gain insight on the year ahead, Curtis Lane, founder of WindRose Health Investors, hosted a panel with some of the leading voices in investment banking. Panelists joining Lane included:

  • Fritz Buerger, Managing Director, Healthcare, Healthcare Services, William Blair
  • Richard Harding, Managing Director and Head of the US Private Equity Solutions Group, Moelis & Company
  • Philip Pucciarelli, Partner, Perella Weinberg Partners
  • Geoffrey Smith, Managing Director and Co-Head of the Healthcare & Life Sciences Group, Harris Williams

Access the full takeaways here.
Watch the session recording here.




HPE New York 2021: Super Charging Sellers’ Strategies


Fueled by historically low interest rates, all time high levels of committed—but unallocated—capital and impending tax reform, private equity deal volume and values have reached new, record-breaking heights, and they continue to rise during what everyone predicts will be a very strong fourth quarter. Frank Steinherr, co-head of the Private Equity Practice Group at McDermott, was joined by industry leaders to make sense of this very frothy and seller-friendly deal environment. The panel included:

  • Megan Preiner, Partner, Thomas H. Lee Partners
  • Geoff Lieberthal, Partner, Two Sigma Impact
  • Chris Harris, Managing Partner, FFL Partners

Access the full takeaways here.
Watch the session recording here.




STAY CONNECTED

TOPICS

ARCHIVES